1. Home
  2. BHVN vs CCB Comparison

BHVN vs CCB Comparison

Compare BHVN & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CCB
  • Stock Information
  • Founded
  • BHVN 2013
  • CCB 1997
  • Country
  • BHVN United States
  • CCB United States
  • Employees
  • BHVN N/A
  • CCB N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CCB Major Banks
  • Sector
  • BHVN Health Care
  • CCB Finance
  • Exchange
  • BHVN Nasdaq
  • CCB Nasdaq
  • Market Cap
  • BHVN 1.5B
  • CCB 1.7B
  • IPO Year
  • BHVN 2017
  • CCB 2018
  • Fundamental
  • Price
  • BHVN $14.72
  • CCB $110.37
  • Analyst Decision
  • BHVN Strong Buy
  • CCB Strong Buy
  • Analyst Count
  • BHVN 16
  • CCB 3
  • Target Price
  • BHVN $52.13
  • CCB $105.00
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • CCB 109.4K
  • Earning Date
  • BHVN 11-11-2025
  • CCB 10-27-2025
  • Dividend Yield
  • BHVN N/A
  • CCB N/A
  • EPS Growth
  • BHVN N/A
  • CCB 18.14
  • EPS
  • BHVN N/A
  • CCB 3.25
  • Revenue
  • BHVN N/A
  • CCB $336,394,000.00
  • Revenue This Year
  • BHVN N/A
  • CCB $83.27
  • Revenue Next Year
  • BHVN $2,195.07
  • CCB $35.03
  • P/E Ratio
  • BHVN N/A
  • CCB $33.90
  • Revenue Growth
  • BHVN N/A
  • CCB 28.83
  • 52 Week Low
  • BHVN $12.79
  • CCB $50.06
  • 52 Week High
  • BHVN $55.70
  • CCB $118.00
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 49.97
  • CCB 54.02
  • Support Level
  • BHVN $13.41
  • CCB $106.50
  • Resistance Level
  • BHVN $14.23
  • CCB $112.45
  • Average True Range (ATR)
  • BHVN 0.86
  • CCB 2.88
  • MACD
  • BHVN -0.17
  • CCB -0.89
  • Stochastic Oscillator
  • BHVN 33.98
  • CCB 33.65

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

Share on Social Networks: